Immediate action must be taken to ensure more effective and equitable implementation of cancer screening, according to a report released by the President’s Cancer Panel.
Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a recent study led by researchers at NYU Langone Health and its Perlmutter Cancer Center shows.
